Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostanoid synthesis by human umbilical artery.

J M Ritter, M A Ongari, S E Barrow

    Prostaglandins
    |December 1, 1982
    PubMed
    Summary

    Human umbilical arteries produce less prostacyclin (PGI2) than previously reported. This study clarifies PGI2 production levels, correcting earlier overestimations by about 100-fold.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Number and location of drainage catheter side holes: in vitro evaluation.

    Clinical radiology·2015
    Same author

    Regulation of lipid synthesis by the RNA helicase Mov10 controls Wnt5a production.

    Oncogenesis·2015
    Same author

    Stable isotope dilution gas chromatography/mass spectrometry of prostaglandins and leukotrienes.

    Biological trace element research·2013
    Same author

    Neurologic melioidosis in an imported pigtail macaque (Macaca nemestrina).

    Veterinary pathology·2013
    Same author

    Cutaneous lymphomas in European pet rabbits (Oryctolagus cuniculus).

    Veterinary pathology·2012
    Same author

    Cyclooxygenase- and lipoxygenase-mediated DNA damage.

    Cancer metastasis reviews·2011

    Area of Science:

    • Biochemistry
    • Reproductive Biology
    • Pharmacology

    Background:

    • Discrepancies existed between published values of prostacyclin (PGI2) production in human umbilical arteries measured by platelet bioassay versus 6-oxo-PGF1 alpha radioimmunoassay.
    • This suggested the potential production of other anti-aggregatory prostanoids by the tissue.

    Purpose of the Study:

    • To investigate and resolve the discrepancy in reported PGI2 production values from human umbilical arteries.
    • To determine if additional anti-aggregatory substances, besides PGI2, are produced by this tissue.

    Main Methods:

    • Human umbilical artery rings were incubated, and PGI2 was measured using both platelet bioassay and a specific radioimmunoassay.
    • 6-oxo-PGF1 alpha, PGF2 alpha, and TXB2 levels were quantified using gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS).
    • Radioimmunoassay involved comparing hydrolyzed and non-hydrolyzed samples for accurate 6-oxo-PGF1 alpha measurement.

    Main Results:

    • PGI2 concentrations measured by radioimmunoassay and bioassay showed a significant correlation (r = 0.92, p < 0.01).
    • No significant difference was found between the two measurement methods, refuting the presence of additional anti-aggregatory substances.
    • PGI2 production determined by bioassay (mean 1.21 ng/mg/h) was substantially lower than previously reported values (70-325 ng/mg/h), indicating an overestimation by approximately 100-fold in prior studies.

    Conclusions:

    • The human umbilical artery produces significantly less PGI2 than previously estimated.
    • The discrepancy was due to overestimations in earlier studies, not the presence of other anti-aggregatory prostanoids.
    • Accurate quantification of PGI2 production is crucial for understanding vascular physiology and potential therapeutic interventions.

    Related Experiment Videos